Double Synergy Differential Test for detection of plasmid-mediated AmpC-type β-lactamases in Proteus mirabilis

References

1. Adler H., Fenner L., Walter P., Hohler D., Schultheiss E., Oezcan S., Frei R. 2008; Plasmid-mediated AmpC β -lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: prevalence at a Swiss university hospital and occurrence of the different molecular types in Switzerland. J Antimicrob Chemother 61:457–458
   [Google Scholar]
2. Bret L., Chanal-Claris C., Sirot D., Chaibi E. B., Labia R., Sirot J. 1998; Chromosomally encoded AmpC-type β -lactamase in a clinical isolate of Proteus mirabilis . Antimicrob Agents Chemother 42:1110–1114
   [Google Scholar]
3. CLSI 2008; Performance Standards for Antimicrobial Susceptibility Testing , 18th Informational Supplement. M100-S18 Wayne, PA: Clinical and Laboratory Standards Institute;
4. D'Andrea M. M., Nucleo E., Luzzaro F., Giani T., Migliavacca R., Vailati F., Kroumova V., Pagani L., Rossolini G. M. 2006; CMY-16, a novel acquired AmpC-type β -lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from Northern Italy. Antimicrob Agents Chemother 50:618–624 [CrossRef]
   [Google Scholar]
5. Decre D., Verdet C., Raskine L., Blanchard H., Burghoffer B., Philippon A., Sanson-Le-Pors M. J., Petit J. C., Arlet G. 2002; Characterization of CMY-type β -lactamases in clinical strains of Proteus mirabilis and Klebsiella pneumoniae isolated in four hospitals in the Paris area. J Antimicrob Chemother 50:681–688 [CrossRef]
   [Google Scholar]
6. Endimiani A., Luzzaro F., Brigante G., Perilli M., Lombardi G., Amicosante G., Rossolini G. M., Toniolo A. 2005; Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to expression of extended-spectrum β -lactamase. Antimicrob Agents Chemother 49:2598–2605 [CrossRef]
   [Google Scholar]
7. Literacka E., Empel J., Baraniak A., Sadowy E., Hryniewicz W., Gniadkowski M. 2004; Four variants of the Citrobacter freundii AmpC-type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland. Antimicrob Agents Chemother 48:4136–4143 [CrossRef]
   [Google Scholar]
8. Luzzaro F., Brigante G., D'Andrea M. M., Pini B., Giani T., Mantegoli E., Rossolini G. M., Toniolo A. 2009; Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type β -lactamase: epidemiology and clinical management. Int J Antimicrob Agents 33:328–333 [CrossRef]
   [Google Scholar]
9. Mata C., Mirò E., Rivera A., Mirelis B., Coll P., Navarro F. 2010; Prevalence of acquired AmpC β -lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007. Clin Microbiol Infect 16:472–476 [CrossRef]
   [Google Scholar]
10. Srinivasan U., Zhang L., France A. M., Ghosh D., Shalaby W., Xie J., Marrs C. F., Foxman B. 2007; Probe hybridization array typing: a binary typing method for Escherichia coli . J Clin Microbiol 45:206–214 [CrossRef]
    [Google Scholar]